Bcl-2 blocks p53-dependent apoptosis

Molecular and Cellular Biology

Volumn 14, Issue 4, 1994, Pages 2556-2563

  Chiou, Shiun Kwei ^a   Rao, Lakshmi ^a   White, Eileen ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

APOPTOSIS; ARTICLE; CELL VIABILITY; ELECTROIMMUNOASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH REGULATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MITOSIS INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIROGENESIS;

ADENOVIRIDAE; RODENTIA;

EID: 0028222955     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.14.4.2556     Document Type: Article

References (46)

1. Alnemri, E. S., T. F. Fernandes, S. Haldar, C. M. Croce, and G. Litwack. 1992. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res. 52:491-495.
2. Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (London) 359:552-554.
3. Chiou, S.-K., and E. White. Unpublished data.
4. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362:849-852.
5. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7:546-554.
6. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
7. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, J. Montgomery, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (London) 356:215-221.
8. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
9. Fanidi, A., E. A. Harrington, and G. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (London) 359:554-556.
10. Gannon, J. V., and D. P. Lane. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature (London) 349:802-806.
11. Henderson, S., M. Rowe, C. Gregory, D. Croom-Crater, F. Wang, R. Longnecker, E. Keiff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115.
12. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cultures. J. Mol. Biol. 26:365-369.
13. Hockenbery, D., G. Nuñez, C. Milliman, R. D. Schreiber, and S. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348:334-336.
14. Hollstein, M., D. Sidransky, B. Vogelstein, and C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
15. Kaczmarek, L., B. Ferguson, M. Rosenberg, and R. Baserga. 1986. Induction of cellular DNA synthesis by purified adenovirus E1A proteins. Virology 152:1-10.
16. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 13:587-597.
17. Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (London) 361: 739-742.
18. Lowe, S., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
19. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847-849.
20. Malkin, D., F. P. Li, L. C. Strong, J. F. J. Fraumeni, C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff, M. A. Tainsky, and S. H. Friend. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
21. Martinez, J., I. Georgoff, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
22. McDonnell, T. J., and S. J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). Nature (London) 349:254-256.
23. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-681.
24. Nuñez, G., D. Hockenbery, T. J. McDonnell, C. M. Sorensen, and S. J. Korsmeyer. 1991. Bcl-2 maintains B cell memory. Nature (London) 353:71-73.
25. Raff, M. C. 1992. Social controls on cell survival and cell death. Nature (London) 356:398-400.
26. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
27. Ryan, J. J., R. Danish, C. A. Gottlieb, and M. F. Clarke. 1993. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol. 13:711-719.
28. Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus E1b-58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387-394.
29. Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888.
30. Stabel, S., P. Argos, and L. Philipson. 1985. The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J. 4:2329-2336.
31. Strasser, A., A. W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899.
32. Vaux, D. L., S. Cory, and T. M. Adams. 1988. Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-b cells. Nature (London) 335:440-442.
33. Vogelstein, B. 1990. A deadly inheritance. Nature (London) 348:681-682.
34. White, E., and R. Cipriani. 1990. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol. Cell. Biol. 10:120-130.
35. White, E., R. Cipriani, P. Sabbatini, and A. Denton. 1991. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:2968-2978.
36. White, E., and L. R. Gooding. 1994. Regulation of apoptosis by human adenoviruses, p. 111-141. In L. D. Tomei and F. O. Cope (ed.), Apoptosis: the molecular basis for cell death II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. White, E., T. Grodzicker, and B. W. Stillman. 1984. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol. 52:410-419.
38. White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol. 12:2570-2580.
39. White, E., D. Spector, and W. Welch. 1988. Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells. J. Virol. 62:4153-4166.
40. Williams, G. 1991. Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098.
41. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 284:555-556.
42. Wjllie, A. H., K. A. Rose, R. C. Morris, C. M. Steel, E. Foster, and D. A. Spandidos. 1987. Rodent fibroblast tumours expressing human myc and ras genes: growth, matastasis and endogenous oncogene expression. Br. J. Cancer 56:251-259.
43. Yew, P. R., and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (London) 357:82-85.
44. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J.-J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1415-1423.
45. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.
46. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.